MTOR and hepatocellular carcinoma: Moreover, we observed that the activation of PI3K/AKT pathway exhibited a stronger immunoblot activity in HCC cells transfected with Tollip-OE, which were characterized by a significant increase in AKT and mTOR phosphorylation expression, respectively (Figure 4b).